DETAILS TONIGHT. KIM. DEBORAH, MALARIA WAS ERADICATED IN THIS COUNTRY IN THE EARLY 1900S, BUT RESEARCHERS SAY THERE ARE STILL CASES HERE EVERY YEAR. BUT THESE FIVE ARE THE FIRST LOCALLY TRANSMITTED ...
Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI ...
Stephanie Nolen interviewed more than 30 scientists, health officials and other key players in the development of the malaria vaccines to report this article. Nurses in countries from Sierra Leone to ...
Results from a Phase I clinical trial have shown that a monoclonal antibody known as L9LS is safe and highly protective in U.S. adults exposed to the malaria parasite. The use of this antibody could ...
On Tuesday, the U.S. Food and Drug Administration (FDA) placed a clinical hold on BioNTech SE’s (NASDAQ:BNTX) Investigational New Drug application (IND) and the related Phase 1/2a trial evaluating the ...
BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the company's Investigational New Drug application and mid-stage trial evaluating ...
Clinical Trial in Africa Finds Single-Dose Malaria Treatment Combining Four Existing Drugs as Effective as More Onerous Multi-Day, Multi-Dose Regimen Research advance from Gabon presented at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results